Your browser doesn't support javascript.
loading
Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial.
Kim, Sun H; Abbasi, Fahim; Nachmanoff, Clara; Stefanakis, Konstantinos; Kumar, Ajay; Kalra, Bhanu; Savjani, Gopal; Mantzoros, Christos S.
Afiliación
  • Kim SH; Division of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Abbasi F; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA.
  • Nachmanoff C; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, California, USA.
  • Stefanakis K; Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Kumar A; Division of Endocrinology, Gerontology and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
  • Kalra B; Department of Medicine, Boston VA Healthcare System and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Savjani G; Ansh Labs, Webster, Texas, USA.
  • Mantzoros CS; Ansh Labs, Webster, Texas, USA.
Diabetes Obes Metab ; 23(2): 489-498, 2021 02.
Article en En | MEDLINE | ID: mdl-33140542

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido 1 Similar al Glucagón / Liraglutida Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptido 1 Similar al Glucagón / Liraglutida Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido